Corrigendum: Morin inhibits proliferation of SW480 colorectal cancer cells by inducing apoptosis mediated by reactive oxygen species formation and uncoupling of Warburg effect
Thomas Sithara, K. B. Arun, H. P. Syama, T. R. Reshmitha, P. Nisha

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer, Hypoxia, and Metabolism
In the published article, there was an error in the text values.
A correction has been made to Results, Detection of Cell Apoptosis Using Flow Cytometry. This sentence previously stated:
“The mean percentage of cells in the early apoptotic population and the late apoptotic population on treatment with 150 µM morin for 48 h was 17.26 ± 0.75 and 9.26 ± 0.40, respectively. It was further increased to 11.56 ± 0.37, 15.83 ± 0.41 and 36.3 ± 1.35, 48.76 ± 0.2 after exposure to 200 and 250 µM morin, respectively, which was significantly different from control cell population (early apoptotic: 1.4 ± 0.2 and late apoptotic: 0.3 ± 0.1). The increment in the late apoptotic population on morin treatment (250 µM) was significantly higher than that of the positive control, camptothecin (early apoptotic: 14.8 ± 0.12 and late apoptotic: 30.2 ± 0.18)”.
The corrected sentence appears below:
“The mean percentage of cells in the early apoptotic population and the late apoptotic population on treatment with 150 µM morin for 48 h was 17.26 ± 0.75 and 15.83 ± 0.41, respectively. It was further changed to 9.26 ± 0.40 and 11.56 ± 0.37 and 36.3 ± 0.42, 48.76 ± 0.20, respectively, after exposure to 200 and 250 µM morin, which was significantly different from control cell population (early apoptotic: 1.4 ± 0.2 and late apoptotic: 0.3 ± 0.1). The increment in the late apoptotic population on morin treatment (200 µM and 250 µM) were significantly higher than that of the positive control, camptothecin (early apoptotic: 30.2 ± 0.3 and late apoptotic: 14.8 ± 0.35).”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
